Optogenetic therapy improves light sensitivity in people with retinitis pigmentosa
An international research team has reported new results from the first clinical cohort of blind people treated with an optogenetic therapy for advanced retinitis pigmentosa.
Read original article on The Medical News →Related news
-
Current age-based genetic testing in patients with cancer may miss the majority of inherited gene variants
United Kingdom
-
Fat-storing gene emerges as possible contributor to anorexia risk
United Kingdom
-
HPV vaccination linked to lower risk of pregnancy complications
United Kingdom
-
REUP technique expands access to pediatric heart transplants
United Kingdom
-
Epilepsy drugs may reduce effectiveness of hormonal contraceptives
United Kingdom
-
Lessons from tobacco control could help reduce demand for firearms
United Kingdom
-
Gut inflammation may explain food sensitivities in IBD patients
United Kingdom
-
Flexible mesh could power implantable electronics without batteries
United Kingdom